CG
SPPI

Cutler Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Cutler Group’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,400
Closed -$1K – 5747
2022
Q2 		$1K Sell
5,400
-7,400
-58% -$6.52K ﹤0.01% 4825
2022
Q1 		$4K Buy
+12,800
New +$11.8K ﹤0.01% 4370
2018
Q3 		– Sell
-18,200
Closed -$38K – 4883
2018
Q2 		$38K Buy
+18,200
New +$337K ﹤0.01% 1781
2016
Q4 		– Sell
-4,600
Closed -$1K – 7536
2016
Q3 		$1K Buy
+4,600
New +$27.3K ﹤0.01% 6380

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cutler Group's SPPI Position: Q3 2020 in Review

Cutler Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2020, closing a stake of 200 shares.

Cutler Group first reported a position in SPPI in Q1 2017 and held it in 7 quarters. The position peaked at $58K in Q4 2017. 159 funds tracked by Wall St. Rank hold SPPI as of Q3 2020.

  • Cutler Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Cutler Group sold 200 Spectrum Pharmaceuticals Inc shares in Q3 2020.
  • Cutler Group first reported a position in Spectrum Pharmaceuticals Inc in Q1 2017 and held it in 7 quarters.
  • Cutler Group's Spectrum Pharmaceuticals Inc position peaked at $58K in Q4 2017.
  • 159 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2020.

Based on Cutler Group's 13F filing for Q3 2020, filed 27 Oct 2020.